February 21, 2018 / 7:27 AM / 4 months ago

BRIEF-Arix Bioscience And Ipsen Signs Strategic Agreement To Develop And Commercialise Innovative Therapies

Feb 21 (Reuters) - Arix Bioscience Plc:

* ARIX BIOSCIENCE AND IPSEN SIGN A STRATEGIC AGREEMENT TO DEVELOP AND COMMERCIALISE INNOVATIVE THERAPIES

* IPSEN WILL CONTRIBUTE RESEARCH, DEVELOPMENT AND COMMERCIAL EXPERTISE TO PARTNERSHIP

* ARIX WILL PROVIDE IPSEN WITH ACCESS TO ITS UNIQUE NETWORK OF PROFESSIONAL AND SCIENTIFIC ADVISORS Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below